|
James Yankaskas
|
|
|
Degrees |
![]() |
|
Office:
7007 Thurston-Bowles Bldg. |
|
|
Research Interests:
|
|
N. Sood, L.J. Paradowski, and J.R. Yankaskas. Outcomes of intensive care unit care in adults with cystic fibrosis. Am. J. Respir. Crit. Care Med. 163:335-338, 2001. L. Gao, J.R. Yankaskas, C.M. Fuller, E.J. Sorscher, S. Matalon, H.J. Forman, and C.J. Venglarik. Chlorzoxazone or 1-EBIO increases Na + absorption across cystic fibrosis airway epithelial cells. Am. J. Physiol. 281: L1123-L1129, 2001. S.H. Randell, D.L. Walstad, U.E. Schwab, B.R. Grubb, and J.R. Yankaskas. Isolation and culture of airway epithelial cells from chronically infected human lungs. In Vitro Cell Dev Biol Anim. 2001; 37:480-489. A. D. Betensley, J. R. Yankaskas. Factor VIIa for alveolar hemorrhage in microscopic polyangiitis. (Letter). Am J Respir Crit Care Med 2002; 166:1291-2. J. Mungle, E. H. Burker, J. R. Yankaskas. Vocational rehabilitation counseling for adolescents and adults with cystic fibrosis. J. Applied Rehabilitation Counseling. 2002; 33:15-21. U. Schwab, M. Leigh, C. Ribeiro, J. Yankaskas, K. Burns, P. Gilligan, P. Sokol, R. Boucher. Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect Immun. 2002; 70:4547-55. D. Worlitzsch, R. Tarran, M. Ulrich, U. Schwab, A. Cekici, K. C. Meyer, P. Birrer, G. Bellon, J. Berger, T. Weiss, K. Botzenhart, J. R. Yankaskas, S. Randell, R. C. Boucher, G. Doring. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002; 109:317-325. J. C. Lay, M. R. Stang, P. E. Fisher, J. R. Yankaskas, W. D. Bennett. Airway retention of materials of different solubility following local intrabronchial deposition in dogs. J. Aerosol Medicine 2003: 16:153-166. J. R. Yankaskas*, B. C. Marshall*, B. Sufian, R. H. Simon, and D. Rodman. Cystic Fibrosis Adult Care – Consensus Conference Report. Chest 2004; 125:1S-40S. M. Mall, S. M. Kreda, A. Mengos, T. J. Jensen, S. Hirtz, H. H. Seydewitz, J. Yankaskas, K. Kunzelmann, J.R. Riordan, R.C. Boucher. The D F508 mutation results in loss of CFTR function and mature protein in native human colon. J. Clin Invest 2004. Gastroenterology. 2004;126:32-41. M. Nissim-Rafinia, M. Aviram, S.H. Randell, L. Shushi, E. Ozeri, O. Chiba-Falek, O. Eidelman, H.B. Pollard, J.R. Yankaskas, B. Kerem. Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. EMBO Rep. 2004; 5:1071-1077. M.L. Fulcher, S. Gabriel, K.A. Burns, J.R. Yankaskas, S.H. Randell. Well-differentiated human airway epithelial cell cultures. Methods Mol Med. 2005;107:183-206. S.M. Kreda, M. Mall, A. Mengos, L. Rochelle, J. Yankaskas, J.R. Riordan, R.C. Boucher. Characterization of Wild-Type and {Delta}F508 Cystic Fibrosis Transmembrane Regulator in Human Respiratory Epithelia. Mol Biol Cell. 2005 Feb 16; [Epub ahead of print] Flume PA, Yankaskas JR, Ebeling M, Hulsey T, Clark LL. Massive hemoptysis in Non-Refereed Journals and Book Chapters JR Yankaskas and MR Knowles, editors. Cystic Fibrosis in Adults. Lippincott-Raven Publishers, Philadelphia, 1999. JR Yankaskas. Bronchitis, bronchiectasis and cystic fibrosis. In: Infectious Diseases, Vol. 1, David Armstrong and Jonathan Cohen, editors. Mosby and Company, Section 2: 26.1-26.8, 1999. RC Boucher, MR Knowles, and JR Yankaskas. Cystic fibrosis. In: Textbook of Respiratory Medicine, 3rd Edition, J Murray and J Nadel, editors. WB Saunders Co., Philadelphia, pp. 1291-1323, 2000. JR Yankaskas. Cystic fibrosis. In: Respiratory Infections, 3rd Edition, MS Niederman, GA Sarosi, and J Glassroth, editors. Lippincott Williams & Wilkins, Philadelphia, pp. 283-296, 2001. AbstractsLH Burch, JM Rommens, JR Yankaskas, LC Tsui and RC Boucher. Alternative initiation and splicing produce tissue-specific mRNAs. Pediatr Pulmonol. Suppl. 19:172, 1999. L Gao, KJ Kim, JR Yankaskas and HJ Forman. Abnormal glutathione (GSH) release into apical fluid of cystic fibrosis airway epithelium. ICSDT: The First International Conference on Control and Diseases of Sodium Dependent Transport Proteins and Ion Channels (Shizuoka, Japan, August 24-28, 1999) (In Press). BJ Pearce and JR Yankaskas. Ciliated ducts are abnormal in cystic fibrosis airway submucosal glands. Pediatr Pulmonol. Suppl. 19:257, 1999. LG Rochelle, JT Gatzy, JR Yankaskas, and RC Boucher. The role of submucosal gland ducts in airway secretions. Pediatr Pulmonol. Suppl. 19:256, 1999. SW Miller, MN Becker, SH Bernacki, AL Nelson, JR Yankaskas and SH Randell. Clara cell genes and proteins in human bronchiolar epithelial cell cultures. Am J Respir Crit Care Med. 161:A150, 2000. JR Yankaskas. Pro: Antibiotic resistant infections should prevent lung transplant in CF. Pediatr Pulmonol. Suppl. 20:163, 2000. L Gao, JR Yankaskas, HJ Forman and CJ Venglarik. 1-EBIO or chlorzoxazone increases amiloride-sensitive Na+ absorption across cystic fibrosis airway epithelial cells. Pediatr Pulmonol. Suppl. 20:203, 2000. LG Rochelle, JT Gatzy, JR Yankaskas and RC Boucher. Ion flow across excised CF and non-CF human bronchi. Pediatr Pulmonol. Suppl. 20:208, 2000. U Schwab, P Gilligan, R Boucher, S Randell and J Yankaskas. Localization of Burkholderia cepacia in well-differentiated human tracheobronchial epithelial cultures. Pediatr. Pulmonol. Suppl. 20:277, 2000.
|
|